Your session is about to expire
← Back to Search
Diabetes Self-Management Education for Diabetes (FDSMEFBO Trial)
N/A
Recruiting
Led By Pearl McElfish, Phd, MDA
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
18 years of age or older
Have T2D (defined as having an HbA1c equal to or greater than 6.5)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediate post-intervention, 6 months post-intervention, 12 months post-intervention, 18 months post-intervention, 24 months post-intervention
Awards & highlights
FDSMEFBO Trial Summary
This trial will test whether the F-DSME diabetes education program is effective when delivered in a group setting in Marshallese Faith Based Organizations.
Who is the study for?
This trial is for Marshallese individuals aged 18 or older with Type 2 Diabetes (T2D), having an HbA1c of at least 6.5, and a family member willing to participate. It's not for those who've had diabetes education in the last five years, plan to move away, or have conditions like terminal illness that would prevent following the study protocol.Check my eligibility
What is being tested?
The study tests if Family Model Diabetes Self-Management Education (F-DSME) is effective when given in group sessions at Marshallese Faith Based Organizations. Previously successful in homes, this trial checks its impact in a new setting.See study design
What are the potential side effects?
Since this intervention involves education and support rather than medication, typical drug side effects are not expected. However, participants may experience stress or emotional discomfort during the learning process.
FDSMEFBO Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
My HbA1c level is 6.5 or higher, indicating I have type 2 diabetes.
FDSMEFBO Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, immediate post-intervention, 6 months post-intervention, 12 months post-intervention, 18 months post-intervention, 24 months post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediate post-intervention, 6 months post-intervention, 12 months post-intervention, 18 months post-intervention, 24 months post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Glycemic Control, Measured by Change in Adjusted Mean HbA1c(%) From Baseline at various time points
FDSMEFBO Trial Design
2Treatment groups
Experimental Treatment
Group I: Wait ListExperimental Treatment1 Intervention
Group II: Family DSMESExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
University of ArkansasLead Sponsor
486 Previous Clinical Trials
149,777 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,215,635 Total Patients Enrolled
Pearl McElfish, Phd, MDAPrincipal InvestigatorUniversity of Arkansas
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am able to follow the study's requirements without major health or mental barriers.I have received diabetes self-management education in the last 5 years.My HbA1c level is 6.5 or higher, indicating I have type 2 diabetes.
Research Study Groups:
This trial has the following groups:- Group 1: Family DSMES
- Group 2: Wait List
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are presently enrolled in this research program?
"Affirmative. The records on clinicaltrials.gov verify that this experiment, which was initially posted on April 21st 2022, is currently soliciting individuals for participation. A total of 576 participants are required from 1 medical facility."
Answered by AI
Is enrollment currently open for this research endeavor?
"Data from clinicaltrials.gov confirms that this study is currently enrolling participants, as the trial was first published on April 21st 2022 and edited for the last time four days later."
Answered by AI
Share this study with friends
Copy Link
Messenger